BioCrossroads

Roche's pTau217 assay* is mentioned as one of TIME's Best Inventions of 2024 in the Medical Care category. This blood test, which is being developed in collaboration with Eli Lilly and Company, will be used to help identify the presence or absence of amyloid pathology in individuals, which can help ensure they are able to receive appropriate care. https://lnkd.in/gfqRmhyc #TIMEBestInventions #Alzheimers *The pTau217 assay is available for research use only, not for use in diagnostic procedures. A similar version of the assay is under development and received FDA Breakthrough Device Designation.

Today's #obesity treatments are a game-changer – but not the end of the game. In fact, several #Hoosier life sciences companies are working to find the next advancement in the treatment of #diabetes and obesity. The annual BioCrossroads Life Sciences Summit will feature Ruth Gimeno of Eli Lilly and Company, Karen Wurster of Adipo Therapeutics, and Michael A. Dorato, PhD, DABT, Fellow ATS, FRSB of MBX Biosciences, Inc. BioSciences. Each company is part of the race to find an even better solution for people who need help. Our event is sold out. You can keep up with the event on November 7 by following BioCrossroads on LinkedIn.

GLP-1s, (glucagon-like peptide-1s) have had a historical effect on obesity and changed the way doctors treat the disease. On November 7, the BioCrossroads Life Sciences Summit will gather key researchers and physicians, including Richard DiMarchi, Robert Considine, Viral Shah, and James Matthew Andry, MD to discuss the real-world implications and their perspectives on these groundbreaking treatments. Keep up with the conversation on November 7 by following us on LinkedIn.

With the rapid rise of AI technology, the upcoming Purdue University AI Summit, presented in partnership with Google, will bring together thought leaders, researchers, and policymakers, to explore the transformative impact of AI across multiple sectors, from #healthcare and #cybersecurity to #agriculture and advanced manufacturing. This is a unique opportunity to dive into discussions on ethical AI, data-driven insights, and future applications that could redefine the way we work and live. Registration is now open! #ai #advancedmanufacturing #data #lifesciences #indiana #purdue

Using a highly promising approach to speed breast cancer diagnostics, researcher W. Andy Tao of the Purdue Institute for Cancer Research is studying how specific blood particles could be used to catch BRCA-related breast cancer before any tumor growth. The research could transform early breast cancer screening — offering hope and a potential lifeline to millions of women worldwide with #BRCA gene mutations. #cancer #oncology #purdue #indiana #womenshealth

Obesity is both a personal health challenge and a societal issue that profoundly impacts communities. Beyond increasing individual risks of hypertension, diabetes, and heart disease, obesity contributes to broader social implications, including mental health challenges and economic burdens. At the upcoming BioCrossroads Life Sciences Summit, Dr. David Allison, Dean of the Indiana University School of Public Health-Bloomington, Dr. Virginia Caine, Director and Chief Medical Officer at the Marion County Health Department, and Indiana Health Commissioner Dr. Lindsay Weaver, will take part in a discussion surrounding the complex impacts of obesity, and strategies for addressing these challenges in our communities. #indiana #lifesciences #healthcare #IN #BioXSummit24

Love seeing the collaboration between OrthoWorx, Inc. and Ball State University, working to find ways to collaborate and grow the #orthopedic industry. #bsu #indiana #lifesciences

The National Cancer Institute (NCI) Institute has renewed the prestigious comprehensive cancer center designation to the IU Simon Comprehensive Cancer Center, awarding it a five-year, $14.2 million grant. This designation affirms that they have access to the most advanced, research-guided therapies, as well as hundreds of clinical studies that test the most promising new ways to treat cancer. #cancer #cancerresearch #oncology #grant #nci #iu #indiana

We are thrilled to announce that the 2024 BioCrossroads Life Sciences Summit is officially sold out! With just one week to go, we are excited to bring together industry leaders, innovators, and advocates to discuss groundbreaking advancements in diabetes and obesity care management, as well as Indiana's pivotal role in this work. If you weren't able to secure a spot, we hope you'll stay tuned on LinkedIn and at BioCrossroads.com for updates and key insights from the event on November 7. #indiana #lifesciences #healthcare #BioXSummit2024

The power of medical innovation becomes undeniable when we hear directly from those it impacts. At the 2024 BioCrossroads Life Sciences Summit on November 7, we'll hear from three remarkable individuals sharing their personal journeys, highlighting real-world solutions that made a difference in their lives, and providing invaluable insights to drive more compassionate and effective approaches to health. #indiana #lifesciences #healthcare #IN #BioXSummit24